Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$4.44 - $8.79 $1.56 Million - $3.09 Million
-351,237 Reduced 78.07%
98,663 $449,000
Q2 2023

Aug 10, 2023

BUY
$5.36 - $9.06 $2.41 Million - $4.08 Million
449,900 New
449,900 $3.17 Million
Q4 2022

Feb 13, 2023

BUY
$5.62 - $10.0 $1.03 Million - $1.83 Million
183,354 Added 260.52%
253,733 $1.62 Million
Q3 2022

Nov 10, 2022

SELL
$9.53 - $13.11 $280,182 - $385,434
-29,400 Reduced 29.47%
70,379 $674,000
Q2 2022

Aug 19, 2022

SELL
$6.38 - $18.33 $246,114 - $707,098
-38,576 Reduced 27.88%
99,779 $1.1 Million
Q1 2022

May 13, 2022

BUY
$12.38 - $19.1 $1.52 Million - $2.35 Million
122,876 Added 793.82%
138,355 $2.3 Million
Q4 2021

Feb 11, 2022

SELL
$16.55 - $27.63 $236,251 - $394,418
-14,275 Reduced 47.98%
15,479 $295,000
Q3 2021

Nov 15, 2021

SELL
$20.35 - $26.63 $465,974 - $609,773
-22,898 Reduced 43.49%
29,754 $734,000
Q2 2021

Aug 16, 2021

BUY
$16.33 - $33.07 $859,807 - $1.74 Million
52,652 New
52,652 $1.37 Million
Q1 2021

May 17, 2021

SELL
$28.67 - $52.59 $1.31 Million - $2.4 Million
-45,671 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$28.04 - $50.26 $855,079 - $1.53 Million
30,495 Added 200.94%
45,671 $2.12 Million
Q3 2020

Nov 16, 2020

SELL
$27.75 - $36.3 $1.99 Million - $2.6 Million
-71,744 Reduced 82.54%
15,176 $500,000
Q2 2020

Aug 14, 2020

BUY
$27.21 - $41.0 $2.37 Million - $3.56 Million
86,920 New
86,920 $2.39 Million

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.21B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.